Trends in reported incidence of primary malignant brain tumors in children in the United States

Journal of the National Cancer Institute

Volumn 90, Issue 17, 1998, Pages 1269-1277

  Smith, Malcolm A ^a,d   Freidlin, Boris ^c   Gloeckler Ries, Lynn A ^b   Simon, Richard ^a  

^a Cancer Therapy Evaluation Program   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c EMMES CORPORATION   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN TUMOR; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; STATISTICS; UNITED STATES;

EID: 0032475398     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.17.1269     Document Type: Article

References (55)

1. Ries LA, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK. editors. SEER cancer statistics review. 1973-1994. Bethesda (MD): National Institutes of Health. National Cancer Institute: 1997 Report No.: DHHS Publ No. (NIH)97-2789.
2. Cushman J. U.S. reshaping cancer strategy as incidence in children rises: increase may be tied to new chemicals in environment. The New York Times. 1997 Sept 29: p. A1.
3. Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL. Trends in cancer incidence among children in the U.S. Cancer 1996;78:532-41.
4. Greig NH, Ries LG, Yancik R, Rapoport SI. Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst 1990;82: 1621-4.
5. Boyle P, Maisonneuve P, Saracci R, Muir CS. Is the increased incidence of primary malignant brain tumors in the elderly real? [editorial]. J Natl Cancer Inst 1990;82:1594-6.
6. Larsen NS. Brain tumor incidence rising: researchers ask why [news]. J Natl Cancer Inst 1993;85:1024-5.
7. Steinberg EP, Sisk JE, Locke KE. X-ray CT and magnetic resonance imagers. Diffusion patterns and policy issues. N Engl J Med 1985;313: 859-64.
8. Steinberg EP. The status of MRI in 1986: rates of adoption in the United States and worldwide. AJR Am J Roentgenol 1986;147:453-5.
9. Peterman SB, Steiner RE, Bydder GM. Magnetic resonance imaging of intracranial tumors in children and adolescents. AJNR Am J Neuroradiol 1984;5:703-9.
10. Coleman L. Magnetic resonance imaging of the supratentorial brain. Geisinger Bull 1987;36:33-40.
11. Boutwell RC, Mitchell JB. Diffusion of new technologies in the treatment of the Medicare population. Implications for patient access and program expenditures. Int J Technol Assess Health Care 1993;9:62-75.
12. Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment. American Academy of Pediatrics Section Statement. Section on Hematology Oncology. Pediatrics 1997;99:139-41.
13. Devesa SS, Blot WJ, Stone BJ, Miller BA, Tarone RE, Fraumeni JF Jr. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87: 175-82.
14. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology. 2nd ed. Geneva: World Health Organization; 1990.
15. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993;33:1026-9: discussion 1029-30.
16. Hueftle MG, Han JS, Kaufman B, Benson JE. MR imaging of brain stem gliomas. J Comput Assist Tomogr 1985;9:263-7.
17. Steinbok P, Boyd MC. Periaqueductal tumor as a cause of late-onset aqueductal stenosis. Childs Nerv Syst 1987;3:170-4.
18. Pollack IF, Pang D, Albright AL. The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 1994;80:681-8.
19. Heideman R, Packer R, Albright L, Freeman C, Rorke L. Tumors of the central nervous system. In: Pizzo P, Poplack D. editors. Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven; 1997. p. 633-97.
20. Rorke LB, Gilles FH, Davis RL, Becker LE. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer 1985;56(7 Suppl):1869-86.
21. Epstein F, McCleary EL. Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 1986;64:11-5.
22. Constantini S, Epstein F. Surgical indication and technical considerations in the management of benign brain stem gliomas. J Neurooncol 1996;28: 193-205.
23. Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP. Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 1986;65: 745-50.
24. Bartolomei JC, Christopher S, Vives K, Spencer DD, Piepmeier JM. Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997;34:79-84.
25. Davis FG, Freels S, Grutsch J, Barlas S, Brem S. Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance. Epidemiology, and End Results (SEER) data, 1973-1991. J Neurosurg 1998;88:1-10.
26. Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, et al. Brainstem gliomas in children. A Children's Cancer Group review of 119 cases. Pediatr Neurosurg 1996;24:185-92.
27. Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, et al. Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 1994;74:1827-34.
28. Evans AE, Jenkin RD, Sposto R, Ortega JA, Wilson CB, Wara W, et al. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990;72:572-82.
29. Gentet JC, Bouffet E, Doz F, Tron P, Roche H, Thyss A, et al. Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. J Neurosurg 1995;82:608-14.
30. Gajjar A, Sanford RA, Heideman R, Jenkins JJ, Walter A, Li Y, et al. Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol 1997;15:2792-9.
31. Garvey M, Packer RJ. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol 1996;28:167-83.
32. Packer RJ, Zimmerman RA, Luerssen TG, Sutton LN, Bilaniuk LT, Bruce DA, et al. Brainstem gliomas of childhood: magnetic resonance imaging. Neurology 1985;35:397-401.
33. Raffel C, Hudgins R, Edwards MS. Symptomatic hydrocephalus: initial findings in brainstem gliomas not detected on computed tomographic scans. Pediatrics 1988;82:733-7.
34. Gilles FH, Sobel EL, Leviton A, Tavare CJ, Hedley-Whyte ET. Histologic feature reliability in childhood neural tumors. Childhood Brain Tumor Consortium. J Neuropathol Exp Neurol 1994;53:559-71.
35. Epstein F, Wisoff JH. Intrinsic brainstem tumors in childhood: surgical indications. J Neurooncol 1988;6:309-17.
36. Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE. Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group. Cancer 1996;77: 555-62.
37. Nishio S, Fukui M, Tateishi J. Brain stem gliomas: a clinicopathological analysis of 23 histologically proven cases. J Neurooncol 1988;6: 245-50.
38. Epstein F, Wisoff JH. Surgical management of brain stem tumors of childhood and adolescence. Neurosurg Clin N Am 1990;1:111-21.
39. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996;24:9-23.
40. Zimmerman RA. Neuroimaging of primary brainstem gliomas: diagnosis and course. Pediatr Neurosurg 1996;25:45-53.
41. Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 1996;24:24-34.
42. Molloy P, Sutton L, Yachnis AT, Rebsamen S. Brainstem neoplasms [clinical conference]. Med Pediatr Oncol 1995;24:379-87.
43. Hoffman HJ, Becker L, Craven MA. A clinically and pathologically distinct group of benign brain stem gliomas. Neurosurgery 1980;7:243-8.
44. Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP, Davidson G. Transependymal benign dorsally exophytic brain stem gliomas in childhood: diagnosis and treatment recommendations. Neurosurgery 1987;20: 439-44.
45. Pollack IF, Hoffman HJ, Humphreys RP, Becker L. The long-term outcome after surgical treatment of dorsally exophytic brain-stein gliomas. J Neurosurg 1993;78:859-63.
46. Epstein F, Wisoff J. Intra-axial tumors of the cervicomedullary junction. J Neurosurg 1987;67:483-7.
47. Chapman P. Indolent gliomas of the midbrain tectum. Concepts Pediatr Neurosurg 1989;10:97-107.
48. May PL, Blaser SI, Hoffman HJ, Humphreys RP, Harwood-Nash DC. Benign intrinsic tectal "tumors" in children. J Neurosurg 1991;74:867-71.
49. Squires LA, Allen JC, Abbott R, Epstein FJ. Focal tectal tumors: management and prognosis. Neurology 1994;44:953-6.
50. Hamilton MG, Lauryssen C, Hagen N. Focal midbrain glioma: long term survival in a cohort of 16 patients and the implications for management. Can J Neurol Sci 1996;23:204-7.
51. Vandertop WP, Hoffman HJ, Drake JM, Humphreys RP, Rutka JT, Armstrong DC, et al. Focal midbrain tumors in children. Neurosurgery 1992; 31:186-94.
52. Raffel C, McComb JG, Bodner S, Gilles FE. Benign brain stem lesions in pediatric patients with neurofibromatosis: case reports. Neurosurgery 1989; 25:959-64.
53. Pollack IF, Mulvihill JJ. Special issues in the management of gliomas in children with neurofibromatosis 1. J Neurooncol 1996;28:257-68.
54. Broniscer A, Gajjar A, Bhargava R, Langston JW, Heideman R, Jones D, et al. Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma. Neurosurgery 1997;40:331-7; discussion 337-8.
55. Molloy PT, Bilaniuk LT, Vaughan SN, Needle MN, Liu GT, Zackai EH, et al. Brainstem tumors in patients with neurofibromatosis type 1: a distinct clinical entity. Neurology 1995;45:1897-902.